Jenny Brändstedt
1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Ovarian cancer subtypes and survival in relation to three comprehensive imaging parameters
(
- Contribution to journal › Article
-
Mark
Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk : Results from the EPIC cohort
(
- Contribution to journal › Article
- 2018
-
Mark
Anti-CA15.3 and Anti-CA125 Antibodies and ovarian cancer risk : Results from the EPIC cohort
(
- Contribution to journal › Article
- 2017
-
Mark
Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models : results from the EPIC cohort
(
- Contribution to journal › Article
- 2015
-
Mark
Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort
(
- Contribution to journal › Article
-
Mark
Fibre intake and incident colorectal cancer depending on fibre source, sex, tumour location and Tumour, Node, Metastasis stage.
(
- Contribution to journal › Article
-
Mark
Inflammatory markers and risk of epithelial ovarian cancer by tumor subtypes: the EPIC cohort.
(
- Contribution to journal › Article
-
Mark
Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort
(
- Contribution to journal › Article
-
Mark
Plasma fetuin-A concentration, genetic variation in the AHSG gene and risk of colorectal cancer
(
- Contribution to journal › Article
- 2014
-
Mark
Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability
(
- Contribution to journal › Article